Seng Chuen Tan is currently working for IMS Health, Asia Pacific, Singapore. One of his research papers are Cost-minimization Analysis between Sevelamer and Lanthanum in Treating Hyperphosphatemia among Patients with End-stage Renal Disease in China. His research interests include Disease burden, Hyperphosphatemia, Cost-minimization.
|